Addictions, Drug & Alcohol Institute

Front Page


December 9, 2024

ADAI Lunch & Learn: Pipe Distribution Through a Syringe Services Program to Reduce Higher Risk Drug Consumption (Jan 16, 12pm PT)

ADAI Lunch & Learn: Pipe Distribution Through a Syringe Services Program to Reduce Higher Risk Drug Consumption. January 16, 2025, 12-1pm PT, Tom Fitzpatrick MD UW Medicine Physician

Join ADAI and presenter Tom Fitzpatrick, MD (UW Physician & Infectious Diseases Fellow) for our next ADAI Lunch & Learn! In this session, Dr. Fitzpatrick will present interim results from his ADAI Small Grants Project. Heroin, fentanyl, methamphetamine, and cocaine can be injected or smoked. Distributing pipes may encourage people who use drugs (PWUD) to…


December 3, 2024

What’s New in Harm Reduction Research (December 2024)

What's New in Harm Reduction Research

A review of recently published research on harm reduction topics – December 2024. Need help getting copies of any of these articles? Email Meg Brunner, MLIS (meganw@uw.edu). Free articles have “(open access)” after the titles; all other articles require a subscription to access. Facilitators and barriers to monitoring and evaluation at syringe service programs. (open access)…


November 14, 2024

New from CERP Director Beatriz Carlini: Report & Recommendations of the High Potency Cannabis Think Tank to the State of California

Report and Recommendations of the High Potency Cannabis Think Tank to the State of CA

ADAI’s Cannabis Education & Research Program Director Beatriz Carlini, PhD, MPH is one of the co-authors of a new report: “Report and Recommendations of the High Potency Cannabis Think Tank to the State of California.” This report was prepared by a committee of scientists (including Dr. Carlini) and medical experts convened by the California Department…


October 25, 2024

ADAI’s CAAHS is Hiring! NWATTC Project Coordinator & ORN Indigenous Communities Tech Transfer Specialist

We're hiring

ADAI’s Center for Advancing Addiction Health Services (CAAHS) is recruiting for two new positions. Click the links below to find out more about each one and apply! Opioid Response Network Indigenous Communities Technology Transfer Specialist (Req 240043): This position will facilitate access to training, consultation, and guidance resources on evidence-based opioid and stimulant use disorder…


October 16, 2024

ADAI Lunch & Learn Webinar: A Socio-Ecological Approach to Deriving Insights about Stigma Relating to Substance Use (Nov. 14, 12pm PT)

ADAI Lunch & Learn on stigma substance use, Nov. 14, 12pm PT

Presenter:Annie Chen, PhDAssociate ProfessorUW Department of Biomedical Informatics and Health Education Stigma relating to substance use disorder can have negative impacts in many aspects of those affected, including but not limited to physical and mental health, employment, housing, social relationships, and reluctance to seek treatment. Despite these consequences, questions remain concerning how stigma occurs, the…


October 14, 2024

2024 ADAI Symposium: Slides & Recordings Available

ADAI Symposium on Cannabis and Psychotic Disorders

ADAI hosted a day-long research symposium on September 19, 2024 about “Cannabis, Schizophrenia, and Other Psychotic Disorders,” featuring experts like Marta Di Forti, MD, PhD of King’s College (UK) and Deepak Cyril D’Souza, MD of Yale University. Presentations covered the past, present, and future of cannabis use and psychosis; reviewing the evidence; promising clinical interventions…


September 20, 2024

New ADAI Research: Community-Based Medications First for Opioid Use Disorder

New ADAI publication

Citation: Banta-Green CJ, Owens MD, Williams JR, Floyd AS, Williams-Gilbert W, Kingston S. Community-based medications first for opioid use disorder – Care utilization and mortality outcomes. Substance Abuse and Rehabilitation 2024;15:173-183. The most effective and evidence-based treatments for opioid use disorder (OUD) are medications for OUD (MOUD) like buprenorphine, methadone, and extended-release injectable naltrexone. However,…


September 18, 2024

ADAI Webinar: Insights into Xylazine and Other Emerging Issues in the Drug Supply in WA (Oct 3, 2pm PT)

ADAI Webinar: Insights into Xylazine and Other Emerging Issues in the Drug Supply in WA (Oct 3, 2pm PT)

This webinar will answer frequently asked questions related to xylazine and other emerging issues in the unregulated drug supply in WA State: Presenters will include Caleb Banta-Green, Ben Biamont, and others from the WA State Community Drug Checking Network, as well as well as representatives from the Public Health-Seattle & King County Street Medicine Team….


September 17, 2024

WA State Drug Brief: BTMPS: New Substance Found in Community Drug Checking Samples

New from ADAI CEDEER: WA State Drug Brief

In June 2024, a new substance, Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS), was detected in the unregulated drug supply nationally in community drug testing programs, most commonly in products sold as and containing fentanyl. BTMPS is an industrial chemical with no approved use in humans. The effects of the substance and why it might be in the drug…


September 16, 2024

Results from the PerCH Survey: Report and Webinar Recording

PerCH survey webinar

What do permanent supportive housing residents think about drug use, overdose, where they live, and their service needs? Residents living in permanent supportive housing are at a higher risk to witness or have an overdose. To learn more about this group of people and substance use issues, ADAI Research Coordinator and UW MSW student Saul…



Next page